Calculate Your Salary Ranking
Home > Biospecifics Technologies Salary

Biospecifics Technologies Salary
  • 45
  • 52
  • 79

Biospecifics Technologies average salary is $-, median salary is $- with a salary range from $- to $-.
Biospecifics Technologies salaries are collected from government agencies and companies. Each salary is associated with a real job position. Biospecifics Technologies salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 0 Biospecifics Technologies Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Biospecifics Technologies Salaries (March 1, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Biospecifics Technologies salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Biospecifics Technologies Information
  • BioSpecifics Technologies Corp.
  • Industry: BioTech/Drugs
  • City: Lynbrook, NY
  • BioSpecifics Technologies Corp. is engaged in the business of producing and licensing for sale Collagenase ABC, a fermentation-derived enzyme approved by the United States Food and Drug Administration (FDA) for debriding chronic dermal ulcers and severely burned areas (the topical ointment business). Historically, the Company's revenues have been from one customer in the United States, Abbott Laboratories, which, pursuant to an exclusive licensing agreement, compounds the product into Collagenase Santyl Ointment, a prescription drug used to treat a variety of skin wounds. The Company also earns royalties on the sale of Santyl to distributors by Smith & Nephew, Inc. In